Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

on behalf of the ESMO Guidelines Committee

doi:10.1093/annonc/mdx225

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

on behalf of the ESMO Guidelines Committee

Research output: Contribution to journal › Article › peer-review

1674 Citations (Scopus)

Original language	English
Pages (from-to)	iv119-iv142
Journal	Annals of Oncology
Volume	28
DOIs	https://doi.org/10.1093/annonc/mdx225
Publication status	Published - 1 Jan 2017

Access to Document

10.1093/annonc/mdx225

Cite this

@article{dc39304c7a4f46a9afc132235612dec9,

title = "Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",

author = "{on behalf of the ESMO Guidelines Committee} and Haanen, {J. B.A.G.} and F. Carbonnel and C. Robert and Kerr, {K. M.} and S. Peters and J. Larkin and K. Jordan",

year = "2017",

month = jan,

day = "1",

doi = "10.1093/annonc/mdx225",

language = "English",

volume = "28",

pages = "iv119--iv142",

journal = "Annals of Oncology",

issn = "0923-7534",

}

TY - JOUR

T1 - Management of toxicities from immunotherapy

T2 - ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

AU - on behalf of the ESMO Guidelines Committee

AU - Haanen, J. B.A.G.

AU - Carbonnel, F.

AU - Robert, C.

AU - Kerr, K. M.

AU - Peters, S.

AU - Larkin, J.

AU - Jordan, K.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85029704664&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx225

DO - 10.1093/annonc/mdx225

M3 - Article

C2 - 28881921

AN - SCOPUS:85029704664

SN - 0923-7534

VL - 28

SP - iv119-iv142

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Access to Document

Other files and links

Cite this